Advertisement

Topics

BeiGene Ltd. Company Profile

13:06 EDT 25th September 2018 | BioPortfolio

BeiGene is an innovative, clinical-stage Chinese oncology R&D company focused on discovering, developing and commercializing targeted and immune-oncology therapeutics through a novel translational research platform that leverages our strong internal oncology biology expertise with unique access to large number of patient-derived tumor biopsies. With a team of 150 scientists and staff, its pipeline is comprised of novel oral small molecules and monoclonal antibodies for cancer. BeiGene Ltd. is a Cayman Islands exempted company that is an investor in and collaborator with BeiGene (Beijing), Co. Ltd. For more information, please visit our website at www.beigene.com.


News Articles [109 Associated News Articles listed on BioPortfolio]

BeiGene and SpringWorks to Pair RAF and MEK Inhibitors in Solid Tumor Combo

BeiGene, a Beijing novel oncology company, will collaborate with New York's SpringWorks Therapeutics, combining BeiGene’s RAF inhibitor with SpringWorks' MEK inhibitor to treat patients with adv...

BeiGene and SpringWorks enter trial collaboration for solid tumors

BeiGene Ltd. and SpringWorks Therapeutics partnered to evaluate the combination of BeiGene’s lifirafenib (GBG283) with SpringWorks’ PD0325901 as a new treatment regimen for solid tumors.

BeiGene Appoints Senior Pharmaceutical Executive Dr. Xiaobin Wu as General Manager of China and President of BeiGene, Ltd.

BEIJING, China and CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovativ...

BeiGene Raised $900 Million in Hong Kong Debut Offering

BeiGene, a Beijing oncology company, hopes to raise $1 billion in a debut offering on the Hong Kong stock exchange. The company is already listed on NASDAQ in the US. BeiGene has five drug candidates ...

BeiGene Accepting Bids from Investors for $1 Billion Hong Kong IPO

BeiGene, a Beijing oncology company, hopes to raise $1 billion in a debut offering on the Hong Kong stock exchange. The company is already listed on NASDAQ in the US. BeiGene has five drug candidates ...

BeiGene adopts GE ‘turnkey’ factory for anti-PD-1 mAb production

BeiGene will use GE Healthcare Life Sciencesâ âoff-the-shelfâ factory to manufacture monoclonal antibodies in Guangdong Province, China.

BeiGene Starts China Phase III Trial of PD-1 Drug in Squamous NSCLC

BeiGene, a Beijing oncology biopharma, has dosed the first patient in a China Phase III trial of its PD-1 antibody as a first-line treatment for lung cancer. According to BeiGene's count, the trial is...

BRIEF—BeiGene appoints new China chief and company president

China and USA-based oncology specialist BeiGene has appointed Xiaobin Wu as general manager of China…

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial

The purpose of this research study is to look at the effects, good or bad, of TetMYB Vaccine in combination with BGB-A317 in patients with advanced or metastatic solid cancers (including c...

Companies [4 Associated Companies listed on BioPortfolio]

BeiGene (Beijing), Co., Ltd.

BeiGene is an innovative Chinese oncology R&D company focusing on discovering, developing and commercializing targeted and immune-oncology therapeutics. With a team of 150 scienti...

BeiGene Ltd.

BeiGene is an innovative, clinical-stage Chinese oncology R&D company focused on discovering, developing and commercializing targeted and immune-oncology therapeutics through a no...

BeiGene, Ltd.

BeiGene is a Chinese life sciences biotechnology company based in the Zhongguancun Life Science Park in Beijing that is focused on discovering and developing innovative oncology d...

Celgene Corporation and BeiGene, Ltd.

More Information about "BeiGene Ltd." on BioPortfolio

We have published hundreds of BeiGene Ltd. news stories on BioPortfolio along with dozens of BeiGene Ltd. Clinical Trials and PubMed Articles about BeiGene Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BeiGene Ltd. Companies in our database. You can also find out about relevant BeiGene Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record